TG Therapeutics Ranked Number One Fastest-Growing Company in Nor
| TGTX Stock | USD 35.00 0.74 2.16% |
Slightly above 70 percent of all TG Therapeutics' investors are curious in acquiring. The analysis of the overall investor sentiment regarding TG Therapeutics suggests that a large number of traders are confidant. TG Therapeutics' investing sentiment can be driven by a variety of factors including economic data, TG Therapeutics' earnings reports, geopolitical events, and overall market trends.
TGTX |
NEW YORK, Nov. 21, 2024 -- TG Therapeutics, Inc. ,today announced it ranked number one on the Deloitte Technology Fast 500, a ranki
Read at gurufocus.com
 |
TG Therapeutics Current Investor Sentiment
Panic Vs Confidence
70
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use TG Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward TG Therapeutics.
News SentimentBullish | Hype SentimentBullish | Insider SentimentDisposing |
TG Therapeutics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards TG Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
TG Therapeutics Fundamental Analysis
We analyze TG Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TG Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TG Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
TG Therapeutics is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
TG Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with TG Therapeutics stock to make a market-neutral strategy. Peer analysis of TG Therapeutics could also be used in its relative valuation, which is a method of valuing TG Therapeutics by comparing valuation metrics with similar companies.
Peers
TG Therapeutics Related Equities
| XFOR | X4 Pharmaceuticals | 11.43 | ||||
| TERN | Terns Pharmaceuticals | 7.82 | ||||
| VKTX | Viking Therapeutics | 2.04 | ||||
| PDSB | PDS Biotechnology | 1.90 | ||||
| AKRO | Akero Therapeutics | 0.28 | ||||
| MDGL | Madrigal Pharmaceuticals | 0.81 | ||||
| EXEL | Exelixis | 1.43 | ||||
| BTAI | BioXcel Therapeutics | 2.17 | ||||
| HEPA | Hepion Pharmaceuticals | 4.48 |
Additional Tools for TGTX Stock Analysis
When running TG Therapeutics' price analysis, check to measure TG Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TG Therapeutics is operating at the current time. Most of TG Therapeutics' value examination focuses on studying past and present price action to predict the probability of TG Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TG Therapeutics' price. Additionally, you may evaluate how the addition of TG Therapeutics to your portfolios can decrease your overall portfolio volatility.